Subcutaneous Neurofibroma Market: How Are MEK Inhibitors and...

ha aggiunto una foto Health

2026-07-28 10:00:27 -

Subcutaneous Neurofibroma Market: How Are MEK Inhibitors and Topical Therapies Redefining Management Beyond Surgical Excision?

Subcutaneous neurofibromas — the benign peripheral nerve sheath tumors arising within the dermis and subcutis, often multiple and disfiguring in neurofibromatosis type 1 (NF1) patients — have historically been managed through surgical debulking with high recurrence rates and functional morbidity, but the Subcutaneous Neurofibroma Market is now reflecting a therapeutic paradigm shift...

0 Commenti 0 condivisioni 20 Views 0 Anteprima